Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhao-Ru Dong

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Cancer Letters|April 27, 2023
Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapyZhao-Ru Dong, Jia-Bin Cai, Guo-Ming Shi, et al.
Journal of Cancer|November 21, 2017
Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A CirrhosisZhao-Ru Dong, Jie Zou, Dong Sun, et al.
Critical Reviews in Oncology/Hematology|February 22, 2023
Systemic therapy with or without locoregional therapy for advanced hepatocellular carcinoma: A systematic review and network meta-analysisZi-Niu Ding, Guang-Xiao Meng, Jun-Shuai Xue, et al.
Biomarker Research|September 10, 2024
Spatial resolved transcriptomics reveals distinct cross-talk between cancer cells and tumor-associated macrophages in intrahepatic cholangiocarcinomaZhao-Ru Dong, Meng-Ya Zhang, Ling-Xin Qu, et al.
Cancer Immunology, Immunotherapy : CII|November 9, 2021
Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysisJun-Shuai Xue, Hui Liu, Guang-Xiao Meng, et al.
Journal of Cancer Research and Clinical Oncology|June 29, 2022
Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysisZi-Niu Ding, Guang-Xiao Meng, Jun-Shuai Xue, et al.
Journal of Cancer Research and Clinical Oncology|April 28, 2022
Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decadesCheng-Long Han, Yu-Chuan Yan, Lun-Jie Yan, et al.
Frontiers in Oncology|April 17, 2023
Clinical effect and follow-up of laparoscopic radical proximal gastrectomy for upper gastric carcinomaWei Meng, Huang Ya-di, Cao Wei-Bo, et al.
Journal of Gastroenterology and Hepatology|January 4, 2021
Effects of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysisZi-Niu Ding, Zhao-Ru Dong, Zhi-Qiang Chen, et al.
Oncotarget|April 29, 2016
UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating Annexin A2Dou-Sheng Bai, Chao Wu, Liu-Xiao Yang, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Cancer Letters|April 27, 2023
Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapyZhao-Ru Dong, Jia-Bin Cai, Guo-Ming Shi, et al.
Journal of Cancer|November 21, 2017
Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A CirrhosisZhao-Ru Dong, Jie Zou, Dong Sun, et al.
Critical Reviews in Oncology/Hematology|February 22, 2023
Systemic therapy with or without locoregional therapy for advanced hepatocellular carcinoma: A systematic review and network meta-analysisZi-Niu Ding, Guang-Xiao Meng, Jun-Shuai Xue, et al.
Biomarker Research|September 10, 2024
Spatial resolved transcriptomics reveals distinct cross-talk between cancer cells and tumor-associated macrophages in intrahepatic cholangiocarcinomaZhao-Ru Dong, Meng-Ya Zhang, Ling-Xin Qu, et al.
Cancer Immunology, Immunotherapy : CII|November 9, 2021
Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysisJun-Shuai Xue, Hui Liu, Guang-Xiao Meng, et al.
Journal of Cancer Research and Clinical Oncology|June 29, 2022
Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysisZi-Niu Ding, Guang-Xiao Meng, Jun-Shuai Xue, et al.
Journal of Cancer Research and Clinical Oncology|April 28, 2022
Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decadesCheng-Long Han, Yu-Chuan Yan, Lun-Jie Yan, et al.
Frontiers in Oncology|April 17, 2023
Clinical effect and follow-up of laparoscopic radical proximal gastrectomy for upper gastric carcinomaWei Meng, Huang Ya-di, Cao Wei-Bo, et al.
Journal of Gastroenterology and Hepatology|January 4, 2021
Effects of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysisZi-Niu Ding, Zhao-Ru Dong, Zhi-Qiang Chen, et al.
Oncotarget|April 29, 2016
UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating Annexin A2Dou-Sheng Bai, Chao Wu, Liu-Xiao Yang, et al.
Pageof 8